Novel brain-on-chip model to revolutionize drug development for neurological disorders

Title Novel brain-on-chip model to revolutionize drug development for neurological disorders
Acronym NEUROCHIP
Start date 2021-10-01
End date 2024-09-30
Sponsor Horizon Europe Framework Programme
Institution NMI Natural and Medical Sciences Institute at the University of Tübingen

Associated cell lines

Project Description

We will deliver a validated and tested version of NEUROCHIP, a ground-breaking brain-on-chip (BoC) system that allows culturing, imaging, and recording of brain organoids from any source. NEUROCHIP offers revolutionary translational power as the world’s first solution that enables robust assessment of neuronal activity in human-derived 3D brain organoids, empowering research and drug development for a wide range of neurological diseases.